M&A

Why This Biotech Stock Looks Prime For A Johnson & Johnson Buyout
Investors Business Daily
Fri, 05/17/19 - 07:14 pm
JNJ
MeiraGTx
M&A
What's taking the FTC so long? Roche won't say, but insists it will bag Spark on time — despite third delay
Endpoints
Tue, 05/14/19 - 11:05 am
Roche
Spark Therapeutics
M&A
J&J's Ethicon Spends $400M for Takeda’s Fibrin Sealant Patch
Medical Devices and Diagnostics Industry
Sat, 05/11/19 - 12:17 pm
JNJ
Ethicon
M&A
Takeda
Fibrin Sealant Patch
surgical patch
TachoSil
devices
Takeda sells Shire’s Xiidra, transfers 400 staffers to Novartis in $3.4B deal
Fierce Pharma
Thu, 05/9/19 - 11:11 am
Takeda
Shire
Novartis
M&A
Xiidra
dry eye disease
Novartis Considers Offer for Takeda Eye-Disease Assets
Bloomberg
Wed, 05/8/19 - 05:25 pm
Novartis
Takeda
Shire
eye disease
M&A
Don't worry about our $19B bond issue, BMS says. With Celgene, we'll have the cash to pay it off
Fierce Pharma
Wed, 05/8/19 - 05:18 pm
M&A
Bristol-Myers Squibb
Celgene
Pfizer agrees on $340M upfront to buy Therachon for dwarfism drug
Fierce Biotech
Wed, 05/8/19 - 10:42 am
Pfizer
Therachon
short-limbed dwarfism
M&A
Where Will Gilead Sciences Spend Its Cash?
Motley Fool
Tue, 05/7/19 - 10:03 am
Gilead Sciences
M&A
Atara
Exelixis
Lundbeck strikes $250M Abide buyout, bagging Tourette's drug
Fierce Biotech
Mon, 05/6/19 - 10:50 am
Lundbeck
Abide Therapeutics
M&A
Tourette's syndrome
WuXi AppTec buys clinical research services firm Pharmapace
Pharmaceutical Business Review
Mon, 05/6/19 - 10:49 am
CROs
M&A
WuXi AppTec
Pharmapace
5 Things You Can Expect for Gilead Sciences With Its New CEO at the Helm
Motley Fool
Sun, 05/5/19 - 10:34 am
Gilead Sciences
Daniel O'Day
M&A
Kite Pharma
filgotinib
These 6 biotech stocks are promising takeover targets
Marketwatch
Thu, 05/2/19 - 11:33 am
M&A
Sarepta Therapeutics
Amarin
Intercept Pharmaceuticals
Immunomedics
Alder Biopharmaceuticals
Biogen
3M to Acquire Acelity for $6.7B
Medical Devices and Diagnostics Industry
Thu, 05/2/19 - 11:21 am
3M
Acelity
KCI
M&A
devices
If you want blockbuster sales, buy them in
EP Vantage
Tue, 04/30/19 - 09:38 am
licensing
M&A
Sanofi's Eloctate, a Bioverativ buyout centerpiece, suffers on Roche's Hemlibra launch
Fierce Pharma
Fri, 04/26/19 - 07:39 pm
Sanofi
Bioverativ
M&A
diabetes
Eloctate
Roche
Hemlibra
Roche delays $4.3B Spark buyout — again — as FTC review drags on
Endpoints
Fri, 04/26/19 - 10:12 am
Roche
Spark Therapeutics
M&A
FTC
UPDATED: Canine club: Elanco Animal Health makes takeover play for partner Aratana in up to $245M deal
Endpoints
Fri, 04/26/19 - 10:01 am
Elanco
M&A
Aratana Therapeutics
animal health
Bristol-Myers Squibb Posts Solid Q1 Results With the Celgene Acquisition Looming
Motley Fool
Thu, 04/25/19 - 07:14 pm
earnings
Bristol-Myers Squibb
Celgene
M&A
Pump the Brakes on the Illumina and Pacific Biosciences Deal
Motley Fool
Sun, 04/21/19 - 12:21 am
Illumina
Pacific Biosciences
DNA sequencing
M&A
Another Week, Another Gene Therapy Buyout: Catalent Pays $1.2B for Paragon
Xconomy
Mon, 04/15/19 - 10:07 am
gene therapy
M&A
Catalent
Paragon Bioservices

Pages